Pseudohypoaldosteronism
4
0
0
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
2 treatments under study, led by Enalapril
Research Leaders
7 sponsors active, led by National Center for Research Resources (NCRR)
Related Conditions
Often studied with 5 related conditions
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 4 trials
100.0%
+13.4% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 3 completed trials
Clinical Trials (4)
Genetic Disorders of Mucociliary Clearance in Nontuberculous Mycobacterial Lung Disease
Transient Pseudohypoaldosteronism Affecting Children With Urinary Tract Malformation
Rare Genetic Disorders of the Breathing Airways
Phase II Study of the Pathophysiology and Treatment With Enalapril and Polystyrene Sulfonate for Pseudohypoaldosteronism, Type I
Research Network
Common Treatments
- Enalapril1
- Polystyrene Sulfonate1
Active Sponsors
- National Center for Research Resources (NCRR)2
- National Institutes of Health (NIH)1
- National Heart, Lung, and Blood Institute (NHLBI)1
- University Hospital, Strasbourg, France1
- University of North Carolina, Chapel Hill1
Top Investigators
University of North Carolina, Chapel Hill
University of Texas
National Heart, Lung, and Blood Institute (NHLBI)
Related Conditions
- Cystic Fibrosis2
- Primary Ciliary Dyskinesia2
- Kartagener Syndrome1
- Chronic Granulomatous Disease1
- Nontuberculous Mycobacterial Infection1